PALO ALTO, Calif., June 11, 2025--(BUSINESS WIRE)--Vivo Capital ("Vivo" or "we"), a leading global investment firm focused exclusively on healthcare and life sciences and an approximately 8% ...
Like you, we are shareholders in Sinovac Biotech Ltd. ("Sinovac" or the "Company"). Heng Ren Partners, LLC ("Heng Ren") manages funds that have held Sinovac shares since 2018. Heng Ren has long ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A medical worker holds a dose of the Sinovac vaccine at a district health facility as Indonesia begins mass ...
Sinovac's COVID-19 vaccine was an estimated 98% effective at preventing death in Indonesian health workers. It was also 96% effective at preventing hospitalization, Indonesian officials said. The data ...
The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) today announced several important decisions to deliver sustainable value to shareholders and strengthen the Company’s governance framework.
Sinovac Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that SINOVAC has received on February 8, 2025 a formal court ...
BEIJING--(BUSINESS WIRE)--SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced it received a drug registration ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results